1. VBL Therapeutics Announces Appointment of Dr. Rachel W. Humphrey to Head of the Scientific Advisory Board

    VBL Therapeutics Announces Appointment of Dr. Rachel W. Humphrey to Head of the Scientific Advisory Board

    VBL Therapeutics, a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announced the appointment of Rachel W. Humphrey, MD, PhD, an expert in oncology drug development and one of the pioneers of the immuno-oncology field, to head of the Company’s Scientific Advisory Board ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are delighted to have Dr. Humphrey join as the head of our Scientific Advisory Board.  She brings a wealth of experience in oncology drug development and has a track record of success in managing product development from pre-IND stage to commercialization.
  3. Topics Mentioned

  4. Authors